SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017497
Filing Date
2019-05-09
Accepted
2019-05-08 20:40:39
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q harp-10q_20190331.htm 10-Q 2410442
2 EX-10.1 harp-ex101_127.htm EX-10.1 23131
3 EX-31.1 harp-ex311_49.htm EX-31.1 23032
4 EX-31.2 harp-ex312_47.htm EX-31.2 23030
5 EX-32.1 harp-ex321_48.htm EX-32.1 11801
  Complete submission text file 0001564590-19-017497.txt   7997174

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT harp-20190331.xml EX-101.INS 1744065
7 XBRL TAXONOMY EXTENSION SCHEMA harp-20190331.xsd EX-101.SCH 49116
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE harp-20190331_cal.xml EX-101.CAL 49536
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE harp-20190331_def.xml EX-101.DEF 189894
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20190331_lab.xml EX-101.LAB 410644
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20190331_pre.xml EX-101.PRE 318438
Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38800 | Film No.: 19808487
SIC: 2836 Biological Products, (No Diagnostic Substances)